Statins may improve circulation in the eye
|
Tweet
|
|
The cholesterol-lowering medications known as Statins may improve circulation in the eye, potentially reducing the risk of certain eye diseases, according to a study in the May issue of Archives of Ophthalmology.
Statins have previously been shown to relax blood vessels and reduce the risk of stroke and heart disease, even in patients without High cholesterol, according to background information in the article. The effect of Statins on circulation in the retina has not been studied previously, but researchers have found that long-term use of Statins may reduce the risk of glaucoma, age-related macular degeneration and other eye conditions. These diseases are thought to be associated with problems in circulation in the eye.
Taiji Nagaoka, M.D., Ph.D., Asahikawa Medical College, Japan, and colleagues randomly assigned 12 healthy men (average age 21 years) to receive either a 20-milligram dose of simvastatin or an identical placebo each morning for seven days.
The researchers measured blood flow in the men’s retinal arteries and veins at the beginning of the study, 90 minutes after administering the drug the first day and at the end of seven days. They also assessed the participants’ blood intraocular pressure, or the pressure within the eyeball. The seven-day regimen was repeated again 28 days after the first phase of the study ended.
Among patients taking Statins, intraocular pressure was reduced 90 minutes after taking the medication and at the seven-day mark. Blood velocity (speed) and blood flow were significantly increased in patients who had taken Statins for seven days, although the size of the blood vessels did not change.
These findings may have implications for several eye diseases, the authors write. For instance, diabetic retinopathy, which occurs when poorly controlled diabetes damages the eyes and which can eventually lead to blindness, was recently linked to reduced blood flow in the eye. “Although the findings in the present study are obtained from healthy men whose physiological response to simvastatin may be different from that of patients with diabetes, the increased retinal blood flow associated with treatment with simvastatin may be a potential therapy for diabetic retinopathy,” the authors write.
http://archopht.ama-assn.org/
Revision date: June 11, 2011
Last revised: by Sebastian Scheller, MD, ScD
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

